Get Involved

The Diabetes Management Special Interest Group is a support network for pharmacists who share an interest in the area of diabetes management.

The Diabetes Management SIG will allow pharmacists in this area of practice to connect with others in the field and provide opportunities to discuss up-to-date disease management information.

Diabetes Management SIG

Education and Training

The Pharmacist & Patient-Centered Diabetes Care

APhA's “The Pharmacist and Patient-Centered Diabetes Care” Certificate Training Program is an educational experience designed to equip pharmacists with the knowledge, skills, and confidence needed to provide effective, evidence-based diabetes care. The program provides comprehensive instruction in current diabetes concepts and standards of care and incorporates case studies and hands-on skills training focused on the situations most likely to be encountered—as well as the services most needed—in community and ambulatory care practice settings.

The Pharmacist & Patient-Centered Diabetes Care Certificate Training Program

Practice Resources

  • Focus On Interchangeable Biosimilar Insulins

    This resource provides a summary for practicing pharmacists on recent developments of interchangeable biosimilar insulins in the treatment of diabetes. Information is included to prepare pharmacists to educate patients and answer questions about biosimilars and the availability of interchangeable biosimilar insulins.

  • Focus On: GLP-1

    This resource provides a summary for practicing pharmacists on pharmacologic approaches to the management of both type 1 and type 2 diabetes. The focus of this resource will be on the management of type 2 diabetes, with an emphasis on the use of glucagon-like peptide-1 (GLP-1) receptor agonists.

  • Focus On: Diabetes – Measures Beyond Hemoglobin A1c

    This resource provides a summary for practicing pharmacists on recent developments in the treatment of diabetes. Key updates to recommendations for people with diabetes are highlighted and emerging information about the importance of time in range and glycemic variability are presented.

Diabetes Technology

  • Practice Insights: Expanding Access to Continuous Glucose Monitoring (CGM) Technology in Community Pharmacies

    Uptake of CGM technology has expanded in recent years, especially since Medicare began providing coverage for CGM devices in 2017. However, many important barriers to use remain. To explore how to utilize community pharmacists to expand patient access to CGM, the American Pharmacists Association (APhA) Foundation convened a virtual roundtable.

  • Personal Contionous Monitoring (CGM) Playbook

    The ADCES and APhA/APhA Foundation Personal CGM Implementation Playbook brings together information available from multiple sources to provide an inclusive and unbiased approach to implementation of Personal CGM into your practice. It includes a step-by-step approach to implementation, additional resources and the latest research.

Clinical Guidelines